| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/20/2000 | EP1035835A1 Long acting injectable formulations containing hydrogenated castor oil |
| 09/20/2000 | EP1035834A1 Osmotic dosage form comprising first and second coats |
| 09/20/2000 | EP1035833A1 Compositions for nasal administration |
| 09/20/2000 | EP1035826A1 Hair and/or body hygienic product for human beings and animals |
| 09/20/2000 | EP1035779A1 Improved chewing gum formulations including aspartame and sodium bicarbonate |
| 09/20/2000 | EP0620730B1 Prolamine coatings for taste-masking orally-administrable medicaments |
| 09/20/2000 | CN2396816Y Acupoint massage medical plaster |
| 09/20/2000 | CN1267232A Process for preparation of vesicles |
| 09/20/2000 | CN1267220A Gelled composition |
| 09/20/2000 | CN1267219A Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 09/20/2000 | CN1267217A Solid pharmaceutical composition contg. benzofurane derivs. |
| 09/20/2000 | CN1267216A In situ formation of polymeric material |
| 09/20/2000 | CN1267215A Pharmacetical compositions contg. effervescent acid-base couple |
| 09/20/2000 | CN1267214A Novel formulations of pharmacological agents, method for preparation thereof and method for use thereof |
| 09/20/2000 | CN1267191A Composition and method for treating penile erectile dysfunction |
| 09/20/2000 | CN1266712A Oral liquid for preventing altitude disease and its preparing process |
| 09/20/2000 | CN1266706A Compound 'Tanxian' pill for treating paralysis and epilepsy |
| 09/20/2000 | CN1266705A Chinese-medicinal pills for treating rheumatism and preparing process thereof |
| 09/20/2000 | CN1266704A Medicine for treating rheumatoid arthritis and preparing process thereof |
| 09/20/2000 | CN1266702A Antidepressive capsule and preparing process thereof |
| 09/20/2000 | CN1266700A Powdered bone-setting medicine |
| 09/20/2000 | CN1266698A Method for replacing Chinese-herbal pieces with single-component Chinese medicine |
| 09/20/2000 | CN1266686A Medicinal composition for treating diabetes |
| 09/20/2000 | CN1266682A Quick-acting aerosol for treating stenocardia and preparing process thereof |
| 09/20/2000 | CN1266679A Nanoemulsion based on ethoxylated fatly ether or ethoxylated fatty ester, and use thereof |
| 09/20/2000 | CN1056532C Blood pressure depressing Yongquan plaster |
| 09/20/2000 | CN1056528C Silk ointment for promoting union of wound surface |
| 09/20/2000 | CN1056515C 'Zizhi' medical cream |
| 09/20/2000 | CN1056511C Process for preparing composition for beauty or pharmaceutical, especially dermotoses and antiallergy by using cucurbin, and use |
| 09/20/2000 | CN1056509C Patches for percutaneous administration of skin whitening material |
| 09/20/2000 | CN1056508C Continuous method of tableting |
| 09/19/2000 | US6121427 Major outer membrane protein CD of branhamella |
| 09/19/2000 | US6121375 Gels formed by the interaction of poly(aldehyde) with various substances |
| 09/19/2000 | US6121329 Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol |
| 09/19/2000 | US6121314 Pharmaceutical composition |
| 09/19/2000 | US6121313 Pharmaceutical composition in a form of self-emulsifying formulation for lipophilic compounds |
| 09/19/2000 | US6121295 Treating diabetic complications by administering an insulin sensitivity enhancer such as pioglitazone in combination with a statin compound such as pravastatin |
| 09/19/2000 | US6121294 Reducing the amount of therapeutic agents administered to a diabetic patient by administering an insulin sensitivity enhancer in combination with an alpha-glucosidase inhibitor as said therapeutic agents; side effect reduction |
| 09/19/2000 | US6121276 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 09/19/2000 | US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
| 09/19/2000 | US6121250 Emulsified liquid agent mainly consisting of water-soluble high-molecular weight compound and electrolyte contains silicone-containing antifoam agent |
| 09/19/2000 | US6120856 Coated, resuspendable magnetically responsive, transition metal oxide particles and method for the preparation thereof |
| 09/19/2000 | US6120807 Prolonged release of GM-CSF |
| 09/19/2000 | US6120806 Oral formulations for controlled release of alcohol deterrents |
| 09/19/2000 | US6120805 Microspheres, process for their preparation and their use |
| 09/19/2000 | US6120804 Topical drug preparations |
| 09/19/2000 | US6120803 Having segment of dosage form that is of sufficient rigidity to withstand contractions of stomach and delay expulsion of dosage form from stomach until substantially all of active agent has been dispensed |
| 09/19/2000 | US6120802 Coextruding thermoplastic, pharmacologically acceptable polymeric binder which is soluble or swellable in physiological environment and pharmaceutical active ingredient; shaping coextruded material to required drug form |
| 09/19/2000 | US6120801 Smooth, uniform and bubble free outer coating appearance to caplets |
| 09/19/2000 | US6120800 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 09/19/2000 | US6120799 For treatment and diagnosisdiseases and abnormalities such as cancer, wound healing, and chronic inflammatory diseases |
| 09/19/2000 | US6120798 Liposome-entrapped polynucleotide composition and method |
| 09/19/2000 | US6120797 N-acyl phosphatidylethanolamine-mediated liposomal drug delivery |
| 09/19/2000 | US6120795 Encapsulation |
| 09/19/2000 | US6120794 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 09/19/2000 | US6120793 Transdermal administering |
| 09/19/2000 | US6120792 Supplying topical anesthetic |
| 09/19/2000 | US6120791 Methods for making controlled release devices for pharmaceuticals |
| 09/19/2000 | US6120789 Non-polymeric sustained release delivery system |
| 09/19/2000 | US6120787 Sustained release particles |
| 09/19/2000 | US6120786 Able to penetrate skin |
| 09/19/2000 | US6120785 Antimycotic ectoparasiticidal product-external use |
| 09/19/2000 | US6120778 Oil in water emulsion |
| 09/19/2000 | US6120761 Mixture containing histidine stabilizer |
| 09/19/2000 | US6120759 Anhydrous skin cleansing agent and use thereof |
| 09/19/2000 | US6120758 Preservative system for topically applied products |
| 09/19/2000 | US6120752 Vial equipped with dispensing valve |
| 09/19/2000 | US6120751 Charged lipids and uses for the same |
| 09/19/2000 | US6120491 Selective removal of benzyl esters to form pendent carboxylic acid groups by palladium-catalyzed hydrogenolysis from poly-arylates and polycarbonates in a tertiary-amide solvent; kinetics; surgical barriers; implant coatings; drug delivery |
| 09/19/2000 | US6119687 Partial liquid breathing of fluorocarbons |
| 09/19/2000 | CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed |
| 09/19/2000 | CA2199294C Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| 09/19/2000 | CA2175494C Microparticular pharmaceutical compositions |
| 09/19/2000 | CA2029673C Process for the production of aqueous mixed micelle solutions |
| 09/14/2000 | WO2000054284A1 Radioactive microsphere and method for preparation thereof |
| 09/14/2000 | WO2000053637A1 INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH η-CYCLODEXTRIN |
| 09/14/2000 | WO2000053566A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 09/14/2000 | WO2000053562A1 Retinoid antagonists and use thereof |
| 09/14/2000 | WO2000053282A1 Crystallization process for producing fine crystal products |
| 09/14/2000 | WO2000053233A1 Use of protein conformation for the protection and release of chemical compounds |
| 09/14/2000 | WO2000053228A2 Use of niaouli essential oil as transdermal permeation enhancer |
| 09/14/2000 | WO2000053226A1 Compositions for promoting percutaneous absorption |
| 09/14/2000 | WO2000053188A1 New combination of r,r-formoterol and budesonide in a pharmaceutical composition useful for treating respiratory disorders, such as asthma, rhinitis and copd |
| 09/14/2000 | WO2000053184A1 Drug composition for percutaneous absorption |
| 09/14/2000 | WO2000053177A1 Liposome preparations |
| 09/14/2000 | WO2000053173A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 09/14/2000 | WO2000053170A1 Means for diagnosing and treating carcinoma |
| 09/14/2000 | WO2000053167A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 09/14/2000 | WO2000053164A1 Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
| 09/14/2000 | WO2000053163A1 Bacterial ghosts as carrier and targeting vehicles |
| 09/14/2000 | WO2000053162A1 Controlled-release compositions of betahistine |
| 09/14/2000 | WO2000053161A2 Microparticles for delivery of nucleic acid |
| 09/14/2000 | WO2000053160A1 Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds |
| 09/14/2000 | WO2000053159A1 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
| 09/14/2000 | WO2000053158A1 Modified carrier particles for use in dry powder inhalers |
| 09/14/2000 | WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation |
| 09/14/2000 | WO2000053139A1 Bandage having a scar treatment pad for scar management and scar repair |
| 09/14/2000 | WO2000037056A3 Composition and method for treating glaucoma |
| 09/14/2000 | WO2000037024A3 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates |
| 09/14/2000 | WO2000036201A3 Magnetized pre-wound sideless bobbins |